Previous close | 21.00 |
Open | 20.04 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 21.00 - 21.00 |
52-week range | 16.65 - 22.14 |
Volume | |
Avg. volume | 1,349 |
Market cap | 85.85B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 15.33 |
EPS (TTM) | 1.37 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 0.80 (3.82%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?